{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:39:30Z","timestamp":1792579170275,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10552-026-02258-6","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:53:55Z","timestamp":1792576435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subnational inequalities and socioeconomic gradients in prostate cancer burden across Mexico, 2000\u20132023"],"prefix":"10.1007","volume":"37","author":[{"given":"Jos\u00e9","family":"Guzm\u00e1n-Esquivel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A.","family":"Hern\u00e1ndez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Hernandez-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayim","family":"Pineda-Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josuel","family":"Delgado-Enciso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Romero-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Rojas-Larios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Meza\u2011Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Cabrera-Licona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osval A.","family":"Montesinos-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandrina","family":"Rodr\u00edguez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Delgado-Enciso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"6","key":"2258_CR1","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.euo.2025.05.007","volume":"8","author":"DKW Leung","year":"2025","unstructured":"Leung DKW, Wong CHM, Ko ICH et al (2025) Global trends in the incidence, mortality, and risk-attributable deaths for prostate, bladder, and kidney cancers: a systematic analysis from the global burden of disease study 2021. Eur Urol Oncol 8(6):1533\u201343","journal-title":"Eur Urol Oncol"},{"key":"2258_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251411011","author":"Z Hu","year":"2025","unstructured":"Hu Z, Zeng D, Zhao X et al (2025) Global disparities and temporal trends in prostate, bladder, and kidney cancer burden among men: a systematic analysis of 204 countries (1990-2021). Cancer Control. https:\/\/doi.org\/10.1177\/10732748251411011","journal-title":"Cancer Control"},{"issue":"6","key":"2258_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030635","volume":"8","author":"S Sumanasuriya","year":"2018","unstructured":"Sumanasuriya S, De Bono J (2018) Treatment of advanced prostate cancer\u2014a review of current therapies and future promise. Cold Spring Harb Perspect Med 8(6):a030635","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10437","key":"2258_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J et al (2024) The lancet commission on prostate cancer: planning for the surge in cases. The Lancet 403(10437):1683\u2013722","journal-title":"The Lancet"},{"issue":"3","key":"2258_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer EJ, Laversanne M, Sung H et al (2025) Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol 87(3):302\u201313","journal-title":"Eur Urol"},{"key":"2258_CR6","doi-asserted-by":"publisher","DOI":"10.4137\/BIC.S31802","volume":"8","author":"PO Gaudreau","year":"2016","unstructured":"Gaudreau PO, Stagg J, Souli\u00e8res D et al (2016) The present and future of biomarkers in prostate cancer: proteomics, genomics, and immunology advancements. Biomark Cancer 8:BIC.S31802","journal-title":"Biomark Cancer"},{"issue":"6","key":"2258_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17061013","volume":"17","author":"LC Ko","year":"2025","unstructured":"Ko LC, Gravina N, Berghausen J et al (2025) Rising trends in prostate cancer among Asian men: global concerns and diagnostic solutions. Cancers (Basel) 17(6):1013","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2258_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11255-023-03653-7","volume":"55","author":"J Guzman-Esquivel","year":"1990","unstructured":"Guzman-Esquivel J, Murillo-Zamora E, Ortiz-Mesina M et al (1990) Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019. Int Urol Nephrol 55(9):2155\u201360","journal-title":"Int Urol Nephrol"},{"issue":"13","key":"2258_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133184","volume":"14","author":"SA Beltran-Ontiveros","year":"2022","unstructured":"Beltran-Ontiveros SA, Fernandez-Galindo MA, Moreno-Ortiz JM et al (2022) Incidence, mortality, and trends of prostate cancer in Mexico from 2000 to 2019: results from the Global Burden of Disease Study 2019. Cancers (Basel) 14(13):3184","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2258_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18122016","volume":"18","author":"J Guzm\u00e1n-Esquivel","year":"2026","unstructured":"Guzm\u00e1n-Esquivel J, Hern\u00e1ndez-Fuentes GA, Pineda-Urbina K et al (2026) Burden and trends of genitourinary cancers across the Americas: a GBD 2023 analysis of regional socioeconomic gradients. Cancers (Basel) 18(12):2016","journal-title":"Cancers (Basel)"},{"key":"2258_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-88392-8","author":"Y Zhang","year":"1990","unstructured":"Zhang Y, Wang P, Jia Z et al (1990) Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-88392-8","journal-title":"Sci Rep"},{"issue":"5","key":"2258_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.21037\/tau-2025-103","volume":"14","author":"X Lin","year":"2025","unstructured":"Lin X, Zhi Y (2025) Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021. Transl Androl Urol 14(5):1238\u201352","journal-title":"Transl Androl Urol"},{"issue":"2","key":"2258_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21149\/10960","volume":"62","author":"A Fernandez-Quilez","year":"2020","unstructured":"Fernandez-Quilez A, Germ\u00e1n Borda M, Carre\u00f1o GL et al (2020) Prostate cancer screening and socioeconomic disparities in Mexican older adults. Salud Publica Mex 62(2):121\u20132","journal-title":"Salud Publica Mex"},{"issue":"1","key":"2258_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12913-025-12497-z","volume":"25","author":"E Bautista-Gonzalez","year":"2025","unstructured":"Bautista-Gonzalez E, Quintero Leyra A, Munoz Rocha TV et al (2025) Assessing disparities in cancer resources distribution in Mexico. BMC Health Serv Res 25(1):564","journal-title":"BMC Health Serv Res"},{"key":"2258_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2025.102862","volume":"97","author":"M Hajizadeh","year":"2025","unstructured":"Hajizadeh M, Ghouti L, Johnston G (2025) Socioeconomic inequalities in prostate cancer mortality in Canada: three decades trend analysis. Cancer Epidemiol 97:102862","journal-title":"Cancer Epidemiol"},{"key":"2258_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fonc.2019.00238","volume":"9","author":"P Dasgupta","year":"2019","unstructured":"Dasgupta P, Baade PD, Aitken JF et al (2019) Geographical variations in prostate cancer outcomes: a systematic review of international evidence. Front Oncol 9:238","journal-title":"Front Oncol"},{"key":"2258_CR17","doi-asserted-by":"crossref","first-page":"s220","DOI":"10.1590\/S0036-36342011000100016","volume":"53","author":"OG Dant\u00e9s","year":"2011","unstructured":"Dant\u00e9s OG, Sesma S et al (2011) Sistema de salud de M\u00e9xico. Salud Publica Mex 53:s220-32","journal-title":"Salud Publica Mex"},{"issue":"1","key":"2258_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12877-025-06528-x","volume":"26","author":"W Ding","year":"2026","unstructured":"Ding W, Li L, Wang ZL et al (2026) Burden of prostate cancer in older adults, 1990\u20132021: a systematic analysis based on the global burden of disease study 2021. BMC Geriatr 26:174","journal-title":"BMC Geriatr"},{"key":"2258_CR19","unstructured":"Institute for Health Metrics and Evaluation (2026). Search | GHDx [Internet]. Global Health Data Exchange 1. Available from: https:\/\/ghdx.healthdata.org\/search\/site\/cancer"},{"issue":"10440","key":"2258_CR20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, Santomauro DF, Aali A et al (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a system\u2026. The Lancet 403(10440):2133\u201361","journal-title":"The Lancet"},{"issue":"10513","key":"2258_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(25)01330-3","volume":"406","author":"AE Schumacher","year":"2025","unstructured":"Schumacher AE, Zheng P, Barber RM et al (2025) Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950\u20132023: a demographic analysis for the Global Burden of Disease Study 2023. The Lancet 406(10513):1731\u2013810","journal-title":"The Lancet"},{"issue":"1","key":"2258_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12885-025-15217-2","volume":"26","author":"H Azarbakhsh","year":"2025","unstructured":"Azarbakhsh H, Rezaei F, Dehghani SP et al (2025) Trend analysis of cancer mortality and years of life lost in the South of Iran 2004\u20132019 Joinpoint regression analysis. BMC Cancer 26(1):21","journal-title":"BMC Cancer"},{"issue":"1","key":"2258_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12963-018-0173-5","volume":"16","author":"CS Tan","year":"2018","unstructured":"Tan CS, St\u00f8er N, Ning Y et al (2018) Quantifying temporal trends of age-standardized rates with odds. Popul Health Metr 16(1):18","journal-title":"Popul Health Metr"},{"issue":"10518","key":"2258_CR24","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","volume":"406","author":"PB Mark","year":"2025","unstructured":"Mark PB, Stafford LK, Grams ME et al (2025) Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet 406(10518):2461\u201382","journal-title":"The Lancet"},{"issue":"1","key":"2258_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0962280217713033","volume":"28","author":"P Chernyavskiy","year":"2019","unstructured":"Chernyavskiy P, Little MP, Rosenberg PS (2019) A unified approach for assessing heterogeneity in age\u2013period\u2013cohort model parameters using random effects. Stat Methods Med Res 28(1):20\u201334","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"2258_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.17843\/rpmesp.2020.373.4929","volume":"37","author":"RR Guti\u00e9rrez-Ju\u00e1rez","year":"2020","unstructured":"Guti\u00e9rrez-Ju\u00e1rez RR, \u00c1lvarez-Ba\u00f1uelos MT, Morales-Romero J et al (2020) Lugar de residencia y grado de marginaci\u00f3n como factores pron\u00f3stico de supervivencia al c\u00e1ncer de pr\u00f3stata en Veracruz, M\u00e9xico. Rev Peru Med Exp Salud Publica 37(3):423\u201330. https:\/\/doi.org\/10.17843\/rpmesp.2020.373.4929","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"2258_CR27","unstructured":"Gobierno de M\u00e9xico 2021 \u00cdndices de marginaci\u00f3n 2020 | Consejo Nacional de Poblaci\u00f3n | Gobierno | gob.mx Consejo Nacional de Poblaci\u00f3n. 1"},{"key":"2258_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.annepidem.2020.01.012","volume":"43","author":"S Xie","year":"2020","unstructured":"Xie S, Hubbard RA, Himes BE (2020) Neighborhood-level Measures of Socioeconomic Status are More Correlated with Individual-level Measures in Urban Areas Compared to Less Urban Areas. Ann Epidemiol 43:37","journal-title":"Ann Epidemiol"},{"key":"2258_CR29","unstructured":"R Core Team (2025) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 20 Mar 2026"},{"issue":"10062","key":"2258_CR30","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE et al (2016) Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. The Lancet 388(10062):e19-23","journal-title":"The Lancet"},{"issue":"3","key":"2258_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/picr.picr_256_23","volume":"15","author":"A Bhatt","year":"2024","unstructured":"Bhatt A (2024) Ethical considerations for real-world evidence studies. Perspect Clin Res 15(3):152","journal-title":"Perspect Clin Res"},{"key":"2258_CR32","doi-asserted-by":"publisher","DOI":"10.48193\/pkxgct57","author":"I Delgado-Enciso","year":"2025","unstructured":"Delgado-Enciso I, Guzm\u00e1n-Esquivel J (2025) C\u00e1ncer de pr\u00f3stata: \u00bfpor qu\u00e9 su mortalidad no est\u00e1 disminuyendo? Rev Mex Urol. https:\/\/doi.org\/10.48193\/pkxgct57","journal-title":"Rev Mex Urol"},{"issue":"11","key":"2258_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","volume":"23","author":"DE Spratt","year":"2025","unstructured":"Spratt DE, Srinivas S, Adra N et al (2025) Prostate cancer, version 3.2026 NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 23(11):469\u201393","journal-title":"J Natl Compr Canc Netw"},{"key":"2258_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-085211","volume":"394","author":"DS Childs","year":"2026","unstructured":"Childs DS, Hahn AW, Ravi P et al (2026) Advances in systemic therapies for advanced prostate cancer. BMJ 394:e085211","journal-title":"BMJ"},{"issue":"15","key":"2258_CR35","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375(15):1425\u201337","journal-title":"N Engl J Med"},{"key":"2258_CR36","unstructured":"European Association of Urology (2026) EAU Guidelines. EAU Guidelines Office, Arnhem, The Netherlands. https:\/\/uroweb.org\/guidelines"},{"issue":"17","key":"2258_CR37","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA et al (2023) Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 388(17):1547\u201358","journal-title":"N Engl J Med"},{"issue":"1","key":"2258_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PPO.0b013e3182467419","volume":"18","author":"MM Kim","year":"2012","unstructured":"Kim MM, Hoffman KE, Levy LB et al (2012) Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 18(1):1\u20138","journal-title":"Cancer J"},{"key":"2258_CR39","doi-asserted-by":"publisher","first-page":"1553747","DOI":"10.3389\/fpubh.2025.1553747","volume":"13","author":"X Liu","year":"1990","unstructured":"Liu X, Jiang H (1990) The global, regional, and national prostate cancer burden and trends from 1990 to 2021, results from the global burden of disease study 2021. Front Public Health 13:1553747","journal-title":"Front Public Health"},{"key":"2258_CR40","unstructured":"Our World in Data (2024) Population, 1950 to 2023. United Nations, World Population Prospects 2024, processed by Our World in Data. https:\/\/ourworldindata.org\/grapher\/population-unwpp"},{"issue":"1","key":"2258_CR41","first-page":"5","volume":"64","author":"P Espinosa-Tamez","year":"2022","unstructured":"Espinosa-Tamez P, Suazo-Zepeda E, S\u00e1nchez-Blas H et al (2022) National and state-level colorectal cancer mortality trends in Mexico, 1998\u20132018. Salud Publica Mex 64(1):5\u201313","journal-title":"Salud Publica Mex"},{"issue":"3","key":"2258_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2025-019891","volume":"11","author":"HA Cabrera-Fuentes","year":"2026","unstructured":"Cabrera-Fuentes HA, Hern\u00e1ndez Huerta MT, Guti\u00e9rrez-Delgado F et al (2026) Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care. BMJ Glob Health 11(3):e019891","journal-title":"BMJ Glob Health"},{"issue":"3","key":"2258_CR43","first-page":"102","volume":"24","author":"IE Ballesteros-Goes","year":"2025","unstructured":"Ballesteros-Goes IE, Manrique-Hern\u00e1ndez EF, Licht-Ardila M et al (2025) Timeliness in cancer care: an analysis of delays in diagnosis and treatment initiation. Gaceta mexicana de oncolog\u00eda 24(3):102\u201310","journal-title":"Gaceta mexicana de oncolog\u00eda"},{"issue":"4","key":"2258_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11019-025-10287-2","volume":"28","author":"B Hofmann","year":"2025","unstructured":"Hofmann B (2025) Addressing the overuse-underuse paradox in healthcare. Med Health Care Philos 28(4):679","journal-title":"Med Health Care Philos"},{"issue":"1","key":"2258_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ejihpe15010007","volume":"15","author":"K Dopelt","year":"2025","unstructured":"Dopelt K (2025) Health disparities: the emerging trends and pressing challenges. Eur J Investig Health Psychol Educ 15(1):7","journal-title":"Eur J Investig Health Psychol Educ"},{"issue":"21","key":"2258_CR46","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.3390\/cancers16213675","volume":"16","author":"MA Jimenez-Rios","year":"2024","unstructured":"Jimenez-Rios MA, Scavuzzo A, Nover\u00f3n NR et al (2024) Lethal prostate cancer in mexico: data from the can.prost mexican registry and a project for early detection. Cancers (Basel). 16(21):3675","journal-title":"Cancers (Basel)."},{"key":"2258_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.17226\/10883","volume-title":"Health literacy: a prescription to end confusion","author":"Lynn Nielsen-Bohlman","year":"2004","unstructured":"Nielsen-Bohlman Lynn, Panzer AM, Kindig DA (2004) Health literacy: a prescription to end confusion. p 345"},{"issue":"1","key":"2258_CR48","first-page":"3061","volume":"6","author":"SS Coughlin","year":"2020","unstructured":"Coughlin SS, Vernon M, Hatzigeorgiou C et al (2020) Health literacy, social determinants of health, and disease prevention and control. J Environ Health Sci 6(1):3061","journal-title":"J Environ Health Sci"},{"issue":"12","key":"2258_CR49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/10810730.2017.1401687","volume":"22","author":"YJ Son","year":"2017","unstructured":"Son YJ, Kim SH, Kim GY et al (2017) Associations between health literacy, cancer-related knowledge, and preventive health behaviors in community-dwelling Korean adults. J Health Commun 22(12):999\u20131006. https:\/\/doi.org\/10.1080\/10810730.2017.1401687","journal-title":"J Health Commun"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02258-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:53:57Z","timestamp":1792576437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02258-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02258-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified secondary data obtained from the Global Burden of Disease (GBD) Study 2023 and publicly available socioeconomic indicators from the Mexican National Population Council (CONAPO). No individual-level data, human participants, biological samples, or identifiable personal information were involved. Therefore, ethics committee approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}